Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000744

COO and General Counsel sold 33,190 shares at an average $34.36 ($1,140,362)

  • COO and General Counsel acquired 85,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
O'Brien Patrick COO and General Counsel 2024-01-03 Sale 10b5-1 −3,849 $31.83 $122,514 408,726 D: show line 1 in the form
O'Brien Patrick COO and General Counsel 2024-01-03 Sale 10b5-1 −2,800 $32.52 $91,056 405,926 D: show line 2 in the form
O'Brien Patrick COO and General Counsel 2024-01-03 Sale 10b5-1 −400 $33.41 $13,364 405,526 D: show line 3 in the form
O'Brien Patrick COO and General Counsel 2024-01-03 Sale 10b5-1 −1,700 $32.65 $55,505 403,826 D: show line 4 in the form
O'Brien Patrick COO and General Counsel 2024-01-04 Sale 10b5-1 −1,600 $32.63 $52,208 402,226 D: show line 5 in the form
O'Brien Patrick COO and General Counsel 2024-01-04 Grant or award 10b5-1 +85,000 487,226 D: show line 6 in the form
O'Brien Patrick COO and General Counsel 2024-01-05 Sale 10b5-1 −1,900 $33.99 $64,581 485,326 D: show line 7 in the form
O'Brien Patrick COO and General Counsel 2024-01-05 Sale 10b5-1 −8,200 $34.99 $286,918 477,126 D: show line 8 in the form
O'Brien Patrick COO and General Counsel 2024-01-05 Sale 10b5-1 −12,741 $35.65 $454,217 464,385 D: show line 9 in the form
Open-market sales · 33,190 sh · avg $34.36 · $1,140,362
Loading xslF345X05/wk-form4_1704502718.xml…